Development and fairness assessment of machine learning models for predicting 30-day readmission after lung cancer surgery.

A Atulya Aman Khosla M Mohammad Arfat Ganiyani (6Miami Cancer Institute, Miami, United States) M Manas Pustake (2Texas Tech University El Paso, El Paso, United States) Y Yagnapriya Ammakola (2Corewell Health William Beaumont University Hospital, Royal Oak, United States) N Nitya Batra (1Mayo Clinic, Hematology & Oncology, Jacksonville, United States) A Akshit Chitkara (1Thomas Jefferson University, Philadelphia, United States) R Rohit Singh Y Yanjia Zhang G Gilbert Revoredo (Baptist Health South Florida, Miami, FL) S Sonal Yadav V Vedant Tripathi (Baptist Health South Florida, Miami, FL) A Anshul Saxena K Karan Jatwani (7George Washington University School of Medicine, Washington DC, United States) I Ishmael A. Jaiyesimi (Corewell Health William Beaumont University Hospital, Royal Oak, MI)

Abstract

1532 Background: Predicting post-surgical readmissions is essential for improving patient outcomes and reducing healthcare costs. While machine learning (ML) models offer high predictive accuracy, they may perpetuate healthcare disparities if not rigorously evaluated for algorithmic bias. In this study, we examine the limitations of ML-based readmission prediction models, highlighting how bias can persist despite strong performance metrics. We also explore the impact of integrating fairness constraints to mitigate these disparities, ensuring equitable clinical decision-making across racial and ethnic groups. Methods: We analyzed National Surgical Quality Improvement Program (NSQIP) data (2016–2020) for 23,843 lung cancer surgery patients. Multiple ML models were developed using demographic, clinical, and laboratory variables. Model performance was assessed using standard accuracy metrics alongside fairness evaluations, including Demographic Parity and Equalized Odds, to measure disparities across racial groups. Results: The cohort had 56.5% females; 66.4% of cases belonged to the White race, 6.3% were Black, and 2.9% belonged to the Hispanic ethnicity. The median [Q1, Q3] was 69.0 [62.0, 74.0] years, and the overall readmission rate was 7.5%. The median operation time was higher among readmitted cases (171 minutes vs. 157.0; p < 0.001). However, there was no clinically significant difference between median [Q1, Q3] LOS between the two groups (4.0 [2.0, 6.0] vs. 4.0 [3.0, 7.0]; p < 0.001). The best-performing model (CatBoost) achieved high accuracy but showed disparities in prediction rates across racial groups (Demographic Parity Difference: 0.030, Equalized Odds Difference: 0.333) since the model disproportionately flagged Hispanic patients for readmission risk while potentially under-identifying risk in other groups. Significant predictors included operative time, preoperative sodium (139 vs. 140 mmol/L, p < 0.001), and COPD status (33.8% vs. 25.3%, p < 0.001). After implementing fairness constraints, the model maintained strong predictive performance while reducing demographic disparities, with selection rates balancing across racial groups (range: 0.51%-3.50%). Conclusions: Despite their high accuracy, ML models for predicting post-surgical readmissions can reinforce existing healthcare disparities. Our findings underscore the importance of fairness-aware modeling to mitigate bias, ensuring equitable clinical decision support. While fairness constraints improved demographic balance, residual disparities persisted, highlighting the need for ongoing scrutiny when deploying AI in clinical settings. This study emphasizes the critical need for continuous fairness evaluation in medical AI applications to prevent unintentional harm to vulnerable patient populations.

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
Pages 1532-1532
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (14)

A

Atulya Aman Khosla

M

Mohammad Arfat Ganiyani

6Miami Cancer Institute, Miami, United States

M

Manas Pustake

2Texas Tech University El Paso, El Paso, United States

Y

Yagnapriya Ammakola

2Corewell Health William Beaumont University Hospital, Royal Oak, United States

N

Nitya Batra

1Mayo Clinic, Hematology & Oncology, Jacksonville, United States

A

Akshit Chitkara

1Thomas Jefferson University, Philadelphia, United States

R

Rohit Singh

Y

Yanjia Zhang

G

Gilbert Revoredo

Baptist Health South Florida, Miami, FL

S

Sonal Yadav

V

Vedant Tripathi

Baptist Health South Florida, Miami, FL

A

Anshul Saxena

K

Karan Jatwani

7George Washington University School of Medicine, Washington DC, United States

I

Ishmael A. Jaiyesimi

Corewell Health William Beaumont University Hospital, Royal Oak, MI